Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.

The reagents are meant for measuring aCL and aβ2GP1 antibody levels in human serum to aid the diagnosis of primary and secondary APS.

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.

The company received conditional approval from New York state for its new systemic lupus erythematosus and rheumatoid arthritis biomarker assays.

Numerous firms reported preliminary revenues along with other business updates on Sunday and Monday ahead of the annual JP Morgan Healthcare Conference.

The rapid spinning disk-based immunoassay technology will enhance BioMérieux's offering at the point of care, the firm said.

Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C ...

The expanded clearance adds the Ventana DP 600 slide scanner to Roche's previous whole-slide imaging system that was cleared last year.

NEW YORK – Revvity said on Friday that its Euroimmun subsidiary has received US Food and Drug Administration 510(k) clearance for an automated immunoassay that is used to aid the diagnosis of androgen ...

NEW YORK – Japanese electronics company NEC announced on Friday that it has signed a memorandum of understanding with Biomy for a joint marketing partnership to develop artificial intelligence-based ...

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.